Skip to main content

Personalized Medicine in Gynecologic Cancer: Fact or Fiction?

Author
Abstract
:

Personalized medicine in gynecologic oncology is an evolving field. In recent years, tumor profiling and large databases such as TCGA and NCI-Match have provided us with enormous amounts of molecular data. Several therapies that capitalize on novel genetic and immune discoveries including VEGF inhibitors, PARP inhibitors, and cancer vaccinations are discussed in this article. Additionally, we have seen direct to consumer marketing play an important role in cancer care and prevention as patients have increased ability to access genetic testing. This presents a unique challenge to gynecologic oncology providers as we learn to navigate the world of personalized medicine.

Year of Publication
:
2020
Journal
:
Surgical oncology clinics of North America
Volume
:
29
Issue
:
1
Number of Pages
:
105-113
ISSN Number
:
1055-3207
URL
:
https://linkinghub.elsevier.com/retrieve/pii/S1055-3207(19)30080-8
DOI
:
10.1016/j.soc.2019.08.008
Short Title
:
Surg Oncol Clin N Am
Download citation